Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 1
1990 1
1991 2
1993 1
1996 3
1999 3
2000 1
2001 1
2002 1
2003 3
2009 3
2010 1
2011 3
2012 1
2013 5
2014 5
2015 2
2016 3
2017 2
2018 4
2019 4
2020 1
2021 5
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice.
Pinter M, Scheiner B, Pinato DJ. Pinter M, et al. Lancet Gastroenterol Hepatol. 2023 Aug;8(8):760-770. doi: 10.1016/S2468-1253(23)00147-4. Epub 2023 Jun 14. Lancet Gastroenterol Hepatol. 2023. PMID: 37327807 Review.
We discuss the challenges in individuals with rare histological subtypes of primary liver cancer, including combined hepatocellular-cholangiocarcinoma, fibrolamellar hepatocellular carcinoma, and sarcomatoid hepatocellular carcinoma. ...
We discuss the challenges in individuals with rare histological subtypes of primary liver cancer, including combined hepatocellular-cholangi …
Fibrolamellar hepatocellular carcinoma.
Liu S, Chan KW, Wang B, Qiao L. Liu S, et al. Am J Gastroenterol. 2009 Oct;104(10):2617-24; quiz 2625. doi: 10.1038/ajg.2009.440. Epub 2009 Jul 28. Am J Gastroenterol. 2009. PMID: 19638962 Review.
Fibrolamellar hepatocellular carcinoma (FHLCC) generally occurs in young individuals lacking a background of chronic liver disease and other risk factors for hepatocellular carcinoma. ...
Fibrolamellar hepatocellular carcinoma (FHLCC) generally occurs in young individuals lacking a background of chronic li …
Fibrolamellar Carcinoma: A Concise Review.
Lin CC, Yang HM. Lin CC, et al. Arch Pathol Lab Med. 2018 Sep;142(9):1141-1145. doi: 10.5858/arpa.2017-0083-RS. Arch Pathol Lab Med. 2018. PMID: 30141990 Free article. Review.
Management of fibrolamellar hepatocellular carcinoma.
Chaudhari VA, Khobragade K, Bhandare M, Shrikhande SV. Chaudhari VA, et al. Chin Clin Oncol. 2018 Oct;7(5):51. doi: 10.21037/cco.2018.08.08. Chin Clin Oncol. 2018. PMID: 30395718 Free article. Review.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a primary liver tumor. ...
Fibrolamellar hepatocellular carcinoma (FLHCC) is a primary liver tumor. ...
Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma.
Simon SM. Simon SM. Nat Rev Cancer. 2023 May;23(5):335-346. doi: 10.1038/s41568-023-00554-w. Epub 2023 Mar 17. Nat Rev Cancer. 2023. PMID: 36932129 Free PMC article. Review.
Yet many advances in cancer biology, such as the realization that there are tumour suppressor genes, have come from studying well-defined, albeit rare, cancers. Fibrolamellar hepatocellular carcinoma (FLC), a typically lethal liver cancer, mainly affects adol …
Yet many advances in cancer biology, such as the realization that there are tumour suppressor genes, have come from studying well-defined, a …
A framework for fibrolamellar carcinoma research and clinical trials.
Dinh TA, Utria AF, Barry KC, Ma R, Abou-Alfa GK, Gordan JD, Jaffee EM, Scott JD, Zucman-Rossi J, O'Neill AF, Furth ME, Sethupathy P. Dinh TA, et al. Nat Rev Gastroenterol Hepatol. 2022 May;19(5):328-342. doi: 10.1038/s41575-022-00580-3. Epub 2022 Feb 21. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35190728 Free PMC article. Review.
Advances in fibrolamellar hepatocellular carcinoma: a review.
Lim II, Farber BA, LaQuaglia MP. Lim II, et al. Eur J Pediatr Surg. 2014 Dec;24(6):461-6. doi: 10.1055/s-0034-1396420. Epub 2014 Dec 8. Eur J Pediatr Surg. 2014. PMID: 25486412 Review.
Fibrolamellar hepatocellular carcinoma is a rare primary liver tumor that often arises in the absence of cirrhosis or viral hepatitis. ...This finding may finally provide the basis for specific diagnostic markers and chemotherapies that patients with this dis …
Fibrolamellar hepatocellular carcinoma is a rare primary liver tumor that often arises in the absence of cirrhosis or v …
62 results